Investor Relations

Financial calendar


 

Subscribe to calendar

Latest press releases

Bulletin from the Annual General Meeting of Expres2ion Biotech Holding AB held on 28 May 2025

The Annual General Meeting 2025 (the "AGM") of ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") was held today on 28 May 2025. Notice of the AGM and complete proposals for resolutions taken are available on the Company's investor website, https://investor.expres2ionbio.com.

Read more

ExpreS2ion Biotech Announces Analysguiden Publishes Equity Research Report

Hørsholm, Denmark, 23 May 2025 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion" or the “Company”) is pleased to announce that Analysguiden has published a new analyst report with a revised price target of SEK 75 (previously SEK 91).

Read more

ExpreS2ion Biotech Announces Pareto Securities Analyst Update on Q1 2025 Results and Clinical Trial Progress

Hørsholm, Denmark, 21 May 2025 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion" or the “Company”) is pleased to announce that that Pareto Securities has published a new analyst newsflash following the Company’s recently reported Q1 2025 financial results and clinical trial developments.

Read more

Latest presentations

Presentation of 2025
first quarter results

15 May 2025

2024 Q4 and Full-Year
Report Webcast

6 February 2025

Stora Aktiedagarna
Stockholm

27 November 2024